Registered Trials

• jRCT2031210679

  Phase 3

  Philippines

  Total Enrollment: 1,500

  Official Trial Registration:

  • jRCT2031210679(Opens in new tab/window)

• NCT05572879

  Phase 3

  Philippines

  Total Enrollment: 4,000

  Official Trial Registration:

  • NCT05572879(Opens in new tab/window)

• NCT05603052

  Phase 3

  Democratic Republic of the Congo

  Total Enrollment: 4,000

  Official Trial Registration:

  • NCT05603052(Opens in new tab/window)

• NCT05534035

  Phase 3

  Total Enrollment: 450

  Official Trial Registration:

  • NCT05534035(Opens in new tab/window)

• NCT05007951

  Phase 3

  New Zealand, Philippines, Republic of Korea, Thailand, Ukraine, Viet Nam

  Total Enrollment: 3,990

  Official Trial Registration:

  • NCT05007951(Opens in new tab/window)

• NCT04864561

  Phase 3

  United Kingdom of Great Britain and Northern Ireland

  Total Enrollment: 4,000

  Official Trial Registration:

  • NCT04864561(Opens in new tab/window)

• NCT05293665

  Phase 3

  United States of America

  Total Enrollment: 1,010

  Official Trial Registration:

  • NCT05293665(Opens in new tab/window)

• NCT05470803

  Phase 3

  Brazil

  Total Enrollment: 360

  Official Trial Registration:

  • NCT05470803(Opens in new tab/window)

• NCT05011526

  Phase 3

  Paraguay

  Total Enrollment: 1,020

  Official Trial Registration:

  • NCT05011526(Opens in new tab/window)

• NCT05198596

  Phase 3

  Thailand

  Total Enrollment: 250

  Official Trial Registration:

  • NCT05198596(Opens in new tab/window)

• NCT05426343

  Phase 3

  Paraguay

  Total Enrollment: 250

  Official Trial Registration:

  • NCT05426343(Opens in new tab/window)

• NCT05387317

  Phase 3

  Indonesia

  Total Enrollment: 800

  Official Trial Registration:

  • NCT05387317(Opens in new tab/window)

• NCT04800133

  Phase 3

  Hong Kong

  Total Enrollment: 900

  Official Trial Registration:

  • NCT04800133(Opens in new tab/window)

• NCT05017792

  Phase 3

  Egypt

  Total Enrollment: 200

  Official Trial Registration:

  • NCT05017792(Opens in new tab/window)

• NCT04756271

  Phase 3

  Egypt

  Total Enrollment: 140

  Official Trial Registration:

  • NCT04756271(Opens in new tab/window)

• ISRCTN89951424, NCT04536051

  Phase 3

  Brazil

  Total Enrollment: 10,300

  Official Trial Registration:

  • ISRCTN89951424(Opens in new tab/window)
  • NCT04536051(Opens in new tab/window)

• NCT04516746

  Phase 3

  Argentina, Chile, Colombia, Peru, United States of America

  Total Enrollment: 32,459

  Official Trial Registration:

  • NCT04516746(Opens in new tab/window)

• NCT04540393

  Phase 3

  Russian Federation

  Total Enrollment: 100

  Official Trial Registration:

  • NCT04540393(Opens in new tab/window)

• NCT04973449

  Phase 2/3

  Brazil, United Kingdom of Great Britain and Northern Ireland

  Total Enrollment: 2,475

  Official Trial Registration:

  • NCT04973449(Opens in new tab/window)

• CTRI/2020/08/027170

  Phase 2/3

  India

  Total Enrollment: 1,600

  Official Trial Registration:

  • CTRI/2020/08/027170(Opens in new tab/window)

• NCT05236491

  Phase 2/3

  Canada

  Total Enrollment: 287

  Official Trial Registration:

  • NCT05236491(Opens in new tab/window)

• NCT04885764

  Phase 2/3

  Egypt

  Total Enrollment: 4,000

  Official Trial Registration:

  • NCT04885764(Opens in new tab/window)

• NCT05059106

  Phase 2/3

  Brazil

  Total Enrollment: 29,637

  Official Trial Registration:

  • NCT05059106(Opens in new tab/window)

• EUCTR2020-001228-32, NCT04400838

  Phase 2/3

  United Kingdom of Great Britain and Northern Ireland

  Total Enrollment: 12,390

  Official Trial Registration:

  • EUCTR2020-001228-32(Opens in new tab/window)
  • NCT04400838(Opens in new tab/window)

• NCT05027672

  Phase 2

  Argentina

  Total Enrollment: 348

  Official Trial Registration:

  • NCT05027672(Opens in new tab/window)

• ISRCTN73765130

  Phase 2

  United Kingdom of Great Britain and Northern Ireland

  Total Enrollment: 2,664

  Official Trial Registration:

  • ISRCTN73765130(Opens in new tab/window)

• NCT05465902

  Phase 2

  Mexico

  Total Enrollment: 600

  Official Trial Registration:

  • NCT05465902(Opens in new tab/window)

• NCT05087368

  Phase 2

  Brazil

  Total Enrollment: 520

  Official Trial Registration:

  • NCT05087368(Opens in new tab/window)

• NCT05197153

  Phase 2

  Taiwan

  Total Enrollment: 960

  Official Trial Registration:

  • NCT05197153(Opens in new tab/window)

• NCT05054621

  Phase 2

  Taiwan

  Total Enrollment: 110

  Official Trial Registration:

  • NCT05054621(Opens in new tab/window)

• NCT05324319

  Phase 2

  Austria

  Total Enrollment: 200

  Official Trial Registration:

  • NCT05324319(Opens in new tab/window)

• NCT04894435

  Phase 2

  Canada

  Total Enrollment: 1,300

  Official Trial Registration:

  • NCT04894435(Opens in new tab/window)

• NCT04988048

  Phase 2

  Argentina

  Total Enrollment: 1,760

  Official Trial Registration:

  • NCT04988048(Opens in new tab/window)

• EUCTR2021-002348-57

  Phase 2

  Austria

  Total Enrollment: 60

  Official Trial Registration:

  • EUCTR2021-002348-57(Opens in new tab/window)

• NCT04962906

  Phase 2

  Argentina

  Total Enrollment: 150

  Official Trial Registration:

  • NCT04962906(Opens in new tab/window)

• NCT04983537

  Phase 2

  Argentina

  Total Enrollment: 120

  Official Trial Registration:

  • NCT04983537(Opens in new tab/window)

• NCT04686773

  Phase 2

  Azerbaijan

  Total Enrollment: 100

  Official Trial Registration:

  • NCT04686773(Opens in new tab/window)

• TCTR20210720005

  Phase 2

  Thailand

  Total Enrollment: 180

  Official Trial Registration:

  • TCTR20210720005(Opens in new tab/window)

• NCT04992182

  Phase 2

  Chile

  Total Enrollment: 534

  Official Trial Registration:

  • NCT04992182(Opens in new tab/window)

• NCT05049226

  Phase 2

  Thailand

  Total Enrollment: 1,320

  Official Trial Registration:

  • NCT05049226(Opens in new tab/window)

• PACTR202206754734018

  Phase 2

  Nigeria

  Total Enrollment: 1,812

  Official Trial Registration:

  • PACTR202206754734018(Opens in new tab/window)

• NCT04907331

  Phase 2

  Austria

  Total Enrollment: 3,000

  Official Trial Registration:

  • NCT04907331(Opens in new tab/window)

• NCT05378191, NCT04860739, EUCTR2021-001978-37

  Phase 2

  Spain

  Total Enrollment: 600

  Official Trial Registration:

  • NCT05378191(Opens in new tab/window)
  • NCT04860739(Opens in new tab/window)
  • EUCTR2021-001978-37(Opens in new tab/window)

• ISRCTN69254139

  Phase 2

  United Kingdom of Great Britain and Northern Ireland

  Total Enrollment: 820

  Official Trial Registration:

  • ISRCTN69254139(Opens in new tab/window)

• NCT04998240

  Phase 2

  Mozambique

  Total Enrollment: 360

  Official Trial Registration:

  • NCT04998240(Opens in new tab/window)

• NCT05162482

  Phase 2

  Pakistan

  Total Enrollment: 1,680

  Official Trial Registration:

  • NCT05162482(Opens in new tab/window)

• TCTR20210722003

  Phase 2

  Thailand

  Total Enrollment: 400

  Official Trial Registration:

  • TCTR20210722003(Opens in new tab/window)

• TCTR20211004005

  Phase 2

  Thailand

  Total Enrollment: 300

  Official Trial Registration:

  • TCTR20211004005(Opens in new tab/window)

• ISRCTN15638344

  Phase 2

  United Kingdom of Great Britain and Northern Ireland

  Total Enrollment: 300

  Official Trial Registration:

  • ISRCTN15638344(Opens in new tab/window)

• NCT04760730

  Phase 1/2

  United Arab Emirates

  Total Enrollment: 100

  Official Trial Registration:

  • NCT04760730(Opens in new tab/window)

• NCT04684446

  Phase 1/2

  Belarus, Russian Federation

  Total Enrollment: 100

  Official Trial Registration:

  • NCT04684446(Opens in new tab/window)

• TCTR20211102006

  Phase 1/2

  Thailand

  Total Enrollment: 105

  Official Trial Registration:

  • TCTR20211102006(Opens in new tab/window)

• NCT05133609

  Phase 1/2

  Brazil

  Total Enrollment: 550

  Official Trial Registration:

  • NCT05133609(Opens in new tab/window)

• PACTR202005681895696

  Phase 1/2

  Kenya

  Total Enrollment: 400

  Official Trial Registration:

  • PACTR202005681895696(Opens in new tab/window)

• PACTR202006922165132, NCT04444674

  Phase 1/2

  South Africa

  Total Enrollment: 2,130

  Official Trial Registration:

  • PACTR202006922165132(Opens in new tab/window)
  • NCT04444674(Opens in new tab/window)

• NCT04568031

  Phase 1/2

  Japan

  Total Enrollment: 256

  Official Trial Registration:

  • NCT04568031(Opens in new tab/window)

• EUCTR2020-001072-15, NCT04324606

  Phase 1/2

  United Kingdom of Great Britain and Northern Ireland

  Total Enrollment: 1,112

  Official Trial Registration:

  • EUCTR2020-001072-15(Opens in new tab/window)
  • NCT04324606(Opens in new tab/window)

• NCT05007275

  Phase 1

  United Kingdom of Great Britain and Northern Ireland

  Total Enrollment: 15

  Official Trial Registration:

  • NCT05007275(Opens in new tab/window)

• NCT04816019

  Phase 1

  United Kingdom of Great Britain and Northern Ireland

  Total Enrollment: 30

  Official Trial Registration:

  • NCT04816019(Opens in new tab/window)